Affiliation:
1. From the Program in Vascular Biology, Division of Genetics, and Division of Plastic Surgery at Children's Hospital, Harvard Medical School, Boston, MA.
Abstract
Abstract
Infantile hemangioma is an endothelial tumor that grows rapidly after birth but slowly regresses during early childhood. Initial proliferation of hemangioma is characterized by clonal expansion of endothelial cells (ECs) and neovascularization. Here, we demonstrated mRNA encoding CD133-2, an important marker for endothelial progenitor cells (EPCs), predominantly in proliferating but not involuting or involuted hemangioma. Progenitor cells coexpressing CD133 and CD34 were detected by flow cytometry in 11 of 12 proliferating hemangioma specimens from children 3 to 24 months of age. Furthermore, in 4 proliferating hemangiomas, we showed that 0.14% to 1.6% of CD45– nucleated cells were EPCs that coexpressed CD133 and the EC marker KDR. This finding is consistent with the presence of KDR+ immature ECs in proliferating hemangioma. Our results suggest that EPCs contribute to the early growth of hemangioma. To our knowledge, this is the first study to show direct evidence of EPCs in a human vascular tumor.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference17 articles.
1. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr. 1955;44: 370-379.
2. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg. 1993;6: 204-218.
3. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994; 93: 2357-2364.
4. Malan E. Vascular Malformations (Angiodysplasias). Milan, Italy: Carlo Erba Foundation; 1974: 1-19.
5. Pack GT, Miller TR. Hemangiomas, classification, diagnosis, and treatment. Angiology. 1950;1: 405-426.
Cited by
178 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献